Search

"You have to understand what they care about and what they invest in and how they trade that off against how much return they're expecting."

"We don't see massive misuse as some people allege. This isn't a rigged game where CEOs are lining their pockets."

The thesis of Prof. David Thesmar's study is that IICCs, not Capm outputs, are the right discount rates to use in each category of company.

Prof. Michelle Hanlon urges caution in determining AFSI for insurers.

"If you combine multiple diseases into a single financial portfolio, all of a sudden the risk-reward trade off becomes more attractive."

Prof. Stuart Madnick says federal law doesn't require companies to report ransomware payments beyond those affecting critical infrastructure.